Procter & Gamble Company (The) $PG Holdings Raised by Joel Isaacson & Co. LLC

Joel Isaacson & Co. LLC increased its position in shares of Procter & Gamble Company (The) (NYSE:PG) by 1.8% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 68,216 shares of the company’s stock after purchasing an additional 1,229 shares during the quarter. Joel Isaacson & Co. LLC’s holdings in Procter & Gamble were worth $10,868,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Laraway Financial Advisors Inc grew its position in shares of Procter & Gamble by 2.8% during the 2nd quarter. Laraway Financial Advisors Inc now owns 3,680 shares of the company’s stock valued at $586,000 after buying an additional 100 shares during the last quarter. Roundview Capital LLC raised its position in shares of Procter & Gamble by 1.3% during the 2nd quarter. Roundview Capital LLC now owns 37,404 shares of the company’s stock worth $5,959,000 after purchasing an additional 491 shares during the period. Sunbeam Capital Management LLC lifted its holdings in shares of Procter & Gamble by 2.6% in the 2nd quarter. Sunbeam Capital Management LLC now owns 46,065 shares of the company’s stock worth $7,339,000 after purchasing an additional 1,175 shares during the last quarter. CFM Wealth Partners LLC lifted its holdings in shares of Procter & Gamble by 4.5% in the 2nd quarter. CFM Wealth Partners LLC now owns 10,524 shares of the company’s stock worth $1,677,000 after purchasing an additional 451 shares during the last quarter. Finally, KLP Kapitalforvaltning AS boosted its position in Procter & Gamble by 1.7% during the 2nd quarter. KLP Kapitalforvaltning AS now owns 964,629 shares of the company’s stock valued at $153,685,000 after purchasing an additional 15,700 shares during the period. 65.77% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Trading Down 1.2%

NYSE PG opened at $150.47 on Tuesday. The firm’s 50 day moving average price is $155.38 and its two-hundred day moving average price is $159.84. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. Procter & Gamble Company has a twelve month low of $149.91 and a twelve month high of $180.43. The stock has a market cap of $352.17 billion, a price-to-earnings ratio of 23.11, a PEG ratio of 4.02 and a beta of 0.36.

Procter & Gamble (NYSE:PG) last issued its earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, topping the consensus estimate of $1.42 by $0.06. The business had revenue of $20.89 billion during the quarter, compared to analysts’ expectations of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.Procter & Gamble’s revenue was up 1.7% compared to the same quarter last year. During the same quarter last year, the firm posted $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current year.

Analyst Ratings Changes

PG has been the topic of a number of recent research reports. BNP Paribas reiterated an “outperform” rating and issued a $177.00 target price on shares of Procter & Gamble in a research note on Friday, August 15th. Evercore ISI reiterated an “in-line” rating and issued a $170.00 price objective (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. JPMorgan Chase & Co. restated a “neutral” rating and issued a $170.00 target price (down previously from $178.00) on shares of Procter & Gamble in a research report on Friday, July 25th. UBS Group set a $180.00 price target on Procter & Gamble and gave the company a “buy” rating in a report on Wednesday, July 30th. Finally, BNP Paribas Exane reduced their price objective on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a research report on Tuesday, September 23rd. Eleven equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and a consensus target price of $173.11.

Insider Buying and Selling

In related news, insider Marc S. Pritchard sold 9,849 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,548,952.23. Following the completion of the sale, the insider directly owned 182,422 shares in the company, valued at approximately $28,689,507.94. This trade represents a 5.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Gary A. Coombe sold 10,194 shares of the stock in a transaction on Thursday, August 21st. The stock was sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the transaction, the chief executive officer owned 34,978 shares in the company, valued at approximately $5,532,120.48. This trade represents a 22.57% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 149,763 shares of company stock worth $23,421,279 over the last ninety days. 0.20% of the stock is currently owned by corporate insiders.

Procter & Gamble Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.